Skip to main content
Top
Published in: Cardiovascular Toxicology 1/2010

01-03-2010

In Utero Exposure of Female CD-1 Mice to AZT and/or 3TC: I. Persistence of Microscopic Lesions in Cardiac Tissue

Authors: Salina M. Torres, Thomas H. March, Meghan M. Carter, Consuelo L. McCash, Steven K. Seilkop, Miriam C. Poirier, Dale M. Walker, Vernon E. Walker

Published in: Cardiovascular Toxicology | Issue 1/2010

Login to get access

Abstract

The current study was designed to delineate temporal changes in cardiomyocytes and mitochondria at the light and electron microscopic levels in hearts of mice exposed transplacentally to commonly used nucleoside analogs (NRTIs). Pregnant CD-1 mice were given 80 mg AZT/kg, 40 mg 3TC/kg, 80 mg AZT/kg plus 40 mg 3TC/kg, or vehicle alone during the last 7 days of gestation, and hearts from female mouse pups were examined at 13 and 26 weeks postpartum for histopathological or ultrastructural changes in cross-sections of both the ventricles and the interventricular septum. Using light microscopy and special staining techniques, transplacental exposure to AZT, 3TC, or AZT/3TC was shown to induce significant histopathological changes in myofibrils; these changes were more widespread at 13 weeks than at 26 weeks postpartum. While most light microscopic lesions resolved, some became more severe between 13 and 26 weeks postpartum. Transplacental NRTI exposure also resulted in progressive drug-specific changes in the number and ultrastructural integrity of cardiac mitochondria. These light and electron microscopic findings show that a subset of changes in cardiac mitochondria and myofibrils persisted and progressed months after transplacental exposure of an animal model to NRTIs, with combined AZT/3TC exposure yielding additive effects compared with either drug alone.
Literature
1.
go back to reference Watts, D. H. (2006). Treating HIV during pregnancy. An update on safety issues. Drug Safety, 29, 467–490.CrossRefPubMed Watts, D. H. (2006). Treating HIV during pregnancy. An update on safety issues. Drug Safety, 29, 467–490.CrossRefPubMed
2.
go back to reference Thorne, C., & Newell, M. L. (2007). Safety of agents used to prevent mother-to-child transmission of HIV: Is there any cause for concern? Drug Safety, 30, 203–213.CrossRefPubMed Thorne, C., & Newell, M. L. (2007). Safety of agents used to prevent mother-to-child transmission of HIV: Is there any cause for concern? Drug Safety, 30, 203–213.CrossRefPubMed
3.
go back to reference European Collaborative Study. (2005). Mother to child transmission of HIV infection in the era of highly active antiretroviral therapy. Clinical Infectious Diseases, 40, 458–465.CrossRef European Collaborative Study. (2005). Mother to child transmission of HIV infection in the era of highly active antiretroviral therapy. Clinical Infectious Diseases, 40, 458–465.CrossRef
4.
go back to reference Poirier, M. C., Olivero, O. A., Walker, D. M., & Walker, V. E. (2004). Perinatal genotoxicity and carcinogenicity of the antiretroviral nucleoside analog drugs. Toxicology and Applied Pharmacology, 199, 151–161.CrossRefPubMed Poirier, M. C., Olivero, O. A., Walker, D. M., & Walker, V. E. (2004). Perinatal genotoxicity and carcinogenicity of the antiretroviral nucleoside analog drugs. Toxicology and Applied Pharmacology, 199, 151–161.CrossRefPubMed
5.
go back to reference Blanche, S., Tardieu, M., Benhammou, V., Warszawski, J., & Rustin, P. (2006). Mitochondrial dysfunction following perinatal exposure to nucleoside analogues. AIDS, 20, 1685–1690.CrossRefPubMed Blanche, S., Tardieu, M., Benhammou, V., Warszawski, J., & Rustin, P. (2006). Mitochondrial dysfunction following perinatal exposure to nucleoside analogues. AIDS, 20, 1685–1690.CrossRefPubMed
6.
go back to reference Walker, V. E., & Poirier, M. C. (2007). Foreword: Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors. Environmental and Molecular Mutagenesis, 48, 159–165.CrossRefPubMed Walker, V. E., & Poirier, M. C. (2007). Foreword: Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors. Environmental and Molecular Mutagenesis, 48, 159–165.CrossRefPubMed
7.
go back to reference Foster, C., & Lyall, H. (2008). HIV and mitochondrial toxicity in children. Journal of Antimicrobial Chemotherapy, 61, 8–12.CrossRefPubMed Foster, C., & Lyall, H. (2008). HIV and mitochondrial toxicity in children. Journal of Antimicrobial Chemotherapy, 61, 8–12.CrossRefPubMed
8.
go back to reference Dagan, T., Sable, C., Bray, J., & Gerschenson, M. (2002). Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: What is the evidence? Mitochondrion, 1, 397–412.CrossRefPubMed Dagan, T., Sable, C., Bray, J., & Gerschenson, M. (2002). Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: What is the evidence? Mitochondrion, 1, 397–412.CrossRefPubMed
9.
go back to reference Lewis, W. (2003). Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: Experimental clarifications and persistent clinical questions. Antiviral Research, 58, 189–197.CrossRefPubMed Lewis, W. (2003). Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: Experimental clarifications and persistent clinical questions. Antiviral Research, 58, 189–197.CrossRefPubMed
10.
go back to reference Lewis, W. (2004). Cardiomyopathy, nucleoside reverse transcriptase inhibitors and mitochondria are linked through AIDS and its therapy. Mitochondrion, 4, 141–152.CrossRefPubMed Lewis, W. (2004). Cardiomyopathy, nucleoside reverse transcriptase inhibitors and mitochondria are linked through AIDS and its therapy. Mitochondrion, 4, 141–152.CrossRefPubMed
11.
go back to reference Spector, S. A., & Saitoh, A. (2006). Mitochondrial dysfunction: Prevention of HIV-1 mother-to-infant transmission outweighs fear. AIDS, 20, 1777–1778.CrossRefPubMed Spector, S. A., & Saitoh, A. (2006). Mitochondrial dysfunction: Prevention of HIV-1 mother-to-infant transmission outweighs fear. AIDS, 20, 1777–1778.CrossRefPubMed
13.
go back to reference Olivero, O. A., Fernandez, J. J., Antiochos, B. B., Wagner, J. L., St. Claire, M. E., & Poirier, M. C. (2002). Transplacental genotoxicity of combined antiretroviral nucleoside analogue therapy in Erythrocebus patas monkeys. Journal of Acquired Immuno Deficiency Syndrome, 29, 323–329. Olivero, O. A., Fernandez, J. J., Antiochos, B. B., Wagner, J. L., St. Claire, M. E., & Poirier, M. C. (2002). Transplacental genotoxicity of combined antiretroviral nucleoside analogue therapy in Erythrocebus patas monkeys. Journal of Acquired Immuno Deficiency Syndrome, 29, 323–329.
14.
go back to reference Torres, S. M., Walker, D. M., Carter, M. M., Cook, D. L., Jr., McCash, C. L., Cordova, E. M., et al. (2007). Mutagenicity of zidovudine, lamivudine, and abacavir following exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations. Environmental and Molecular Mutagenesis, 48, 224–238.CrossRefPubMed Torres, S. M., Walker, D. M., Carter, M. M., Cook, D. L., Jr., McCash, C. L., Cordova, E. M., et al. (2007). Mutagenicity of zidovudine, lamivudine, and abacavir following exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations. Environmental and Molecular Mutagenesis, 48, 224–238.CrossRefPubMed
15.
go back to reference Furman, P. A., Fyfe, J. A., Clair, M. H., Weihhold, K., Rideout, J. L., Freeman, G. A., et al. (1986). Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′triphosphate with human immunodeficiency virus reverse transcriptase. Proceedings of the National Academy of Sciences of the United States of America, 83, 8333–8337.CrossRefPubMed Furman, P. A., Fyfe, J. A., Clair, M. H., Weihhold, K., Rideout, J. L., Freeman, G. A., et al. (1986). Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′triphosphate with human immunodeficiency virus reverse transcriptase. Proceedings of the National Academy of Sciences of the United States of America, 83, 8333–8337.CrossRefPubMed
16.
go back to reference Kakuda, T. M. (2000). Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clinical Therapeutics, 22, 685–708.CrossRefPubMed Kakuda, T. M. (2000). Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clinical Therapeutics, 22, 685–708.CrossRefPubMed
17.
go back to reference Olivero, O. A., Anderson, L. M., Diwan, B. A., Haines, D. C., Harbaugh, S. W., Moskal, T. J., et al. (1997). Transplacental effects of 3′-azido-2′, 3′-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys. Journal of the National Cancer Institute, 89, 1602–1608.CrossRefPubMed Olivero, O. A., Anderson, L. M., Diwan, B. A., Haines, D. C., Harbaugh, S. W., Moskal, T. J., et al. (1997). Transplacental effects of 3′-azido-2′, 3′-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys. Journal of the National Cancer Institute, 89, 1602–1608.CrossRefPubMed
18.
go back to reference Olivero, O. A., Shearer, G. M., Chougnet, C. A., Kovacs, A. A., Landay, A. L., Baker, R., et al. (1999). Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS, 13, 919–925.CrossRefPubMed Olivero, O. A., Shearer, G. M., Chougnet, C. A., Kovacs, A. A., Landay, A. L., Baker, R., et al. (1999). Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS, 13, 919–925.CrossRefPubMed
19.
go back to reference Poirier, M. C., Patterson, T. A., Slikker, W., Jr., & Olivero, O. A. (1999). Incorporation of 3′-azido-3′-deoxythymidine (AZT) into fetal DNA, and fetal tissue distribution of drug, after infusion of pregnant late-term rhesus macaques with a human-equivalent AZT dose. Journal of Acquired Immuno Deficiency Syndrome, 22, 477–483. Poirier, M. C., Patterson, T. A., Slikker, W., Jr., & Olivero, O. A. (1999). Incorporation of 3′-azido-3′-deoxythymidine (AZT) into fetal DNA, and fetal tissue distribution of drug, after infusion of pregnant late-term rhesus macaques with a human-equivalent AZT dose. Journal of Acquired Immuno Deficiency Syndrome, 22, 477–483.
20.
go back to reference Lim, S. E., & Copeland, W. C. (2001). Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. The Journal of Biological Chemistry, 276, 23616–23623.CrossRefPubMed Lim, S. E., & Copeland, W. C. (2001). Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. The Journal of Biological Chemistry, 276, 23616–23623.CrossRefPubMed
21.
go back to reference Brinkman, K., ter Hofstede, J. M., Burger, D. M., Smeitink, J. A. M., & Koopmans, P. P. (1998). Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway. AIDS, 12, 735–1744.CrossRef Brinkman, K., ter Hofstede, J. M., Burger, D. M., Smeitink, J. A. M., & Koopmans, P. P. (1998). Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway. AIDS, 12, 735–1744.CrossRef
22.
go back to reference Bishop, J. B., Tani, Y., Witt, K., Johnson, J. A., Peddada, S., Dunnick, J., et al. (2004). Mitochondrial damage revealed by morphometric and semiquantiative analysis of mouse pup cardiomyocytes following in utero and postnatal exposure to zidovudine and lamivudine. Toxicological Sciences, 8, 12–517. Bishop, J. B., Tani, Y., Witt, K., Johnson, J. A., Peddada, S., Dunnick, J., et al. (2004). Mitochondrial damage revealed by morphometric and semiquantiative analysis of mouse pup cardiomyocytes following in utero and postnatal exposure to zidovudine and lamivudine. Toxicological Sciences, 8, 12–517.
23.
go back to reference Blanche, S., Tardieu, M., Rustin, P., Slama, A., Barret, B., Firtion, G., et al. (1999). Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet, 354, 1084–1089.CrossRefPubMed Blanche, S., Tardieu, M., Rustin, P., Slama, A., Barret, B., Firtion, G., et al. (1999). Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet, 354, 1084–1089.CrossRefPubMed
24.
go back to reference Alimenti, A., Burdgec, D. R., Ogilvie, G. S., Money, D. M., & Forbes, J. C. (2003). Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy. Pediatric Infectious Disease Journal, 22, 782–788.CrossRefPubMed Alimenti, A., Burdgec, D. R., Ogilvie, G. S., Money, D. M., & Forbes, J. C. (2003). Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy. Pediatric Infectious Disease Journal, 22, 782–788.CrossRefPubMed
25.
go back to reference Poirier, M. C., Divi, R. L., Al-Harthi, L., Olivero, O. A., Nguyen, V., Walker, B., et al. (2003). Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. Journal of Acquired Immuno Deficiency Syndrome, 33, 175–183.CrossRef Poirier, M. C., Divi, R. L., Al-Harthi, L., Olivero, O. A., Nguyen, V., Walker, B., et al. (2003). Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. Journal of Acquired Immuno Deficiency Syndrome, 33, 175–183.CrossRef
26.
go back to reference Wutzler, P., & Thust, R. (2001). Genetic risks of antiviral nucleoside analogues-a survey. Antiviral Research, 49, 55–74.CrossRefPubMed Wutzler, P., & Thust, R. (2001). Genetic risks of antiviral nucleoside analogues-a survey. Antiviral Research, 49, 55–74.CrossRefPubMed
27.
go back to reference Kohler, J. J., & Lewis, W. (2007). A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environmental and Molecular Mutagenesis, 48, 166–172.CrossRefPubMed Kohler, J. J., & Lewis, W. (2007). A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environmental and Molecular Mutagenesis, 48, 166–172.CrossRefPubMed
28.
go back to reference Walker, D. M., Poirier, M. C., Campen, M. J., Cook, D. L., Jr., Divi, R. L., Nagashima, K., et al. (2004). Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3′-azido-3′-deoxythymidine. Cardiovascular Toxicology, 4, 133–153.CrossRefPubMed Walker, D. M., Poirier, M. C., Campen, M. J., Cook, D. L., Jr., Divi, R. L., Nagashima, K., et al. (2004). Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3′-azido-3′-deoxythymidine. Cardiovascular Toxicology, 4, 133–153.CrossRefPubMed
29.
go back to reference Chan, S. S., Santos, J. H., Meyer, J. N., Mandavilli, B. S., Cook, D. L., Jr., McCash, C. L., et al. (2007). Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination. Environmental and Molecular Mutagenesis, 48, 190–200.CrossRefPubMed Chan, S. S., Santos, J. H., Meyer, J. N., Mandavilli, B. S., Cook, D. L., Jr., McCash, C. L., et al. (2007). Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination. Environmental and Molecular Mutagenesis, 48, 190–200.CrossRefPubMed
30.
go back to reference Divi, R. L., Leonard, S. L., Kuo, M. M., Nagashima, K., Thamire, C., St.Claire, M. C., et al. (2007). Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity. Environmental and Molecular Mutagenesis, 47, 01–20. Divi, R. L., Leonard, S. L., Kuo, M. M., Nagashima, K., Thamire, C., St.Claire, M. C., et al. (2007). Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity. Environmental and Molecular Mutagenesis, 47, 01–20.
31.
go back to reference Torres, S. M., Divi, R. L., Walker, D. M., McCash, C. L., Carter, M. M., & Campen, M. J., et al. (2010). In utero exposure of female CD-1 mice to AZT and/or 3TC: II. Persistence of functional alterations in cardiac tissue. Cardiovascular Toxicology (in press). Torres, S. M., Divi, R. L., Walker, D. M., McCash, C. L., Carter, M. M., & Campen, M. J., et al. (2010). In utero exposure of female CD-1 mice to AZT and/or 3TC: II. Persistence of functional alterations in cardiac tissue. Cardiovascular Toxicology (in press).
32.
go back to reference Lipshultz, S. E., Shearer, W. T., Rich, K., Thompson, B., Cheng, I., Harmon, T., et al. (2005). Antiretroviral therapy (ART)—associated cardiotoxicity in uninfected but ART-exposed infants born to HIV-infected women: The prospective NHLBI CHAART-1 study. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 28, 9. Lipshultz, S. E., Shearer, W. T., Rich, K., Thompson, B., Cheng, I., Harmon, T., et al. (2005). Antiretroviral therapy (ART)—associated cardiotoxicity in uninfected but ART-exposed infants born to HIV-infected women: The prospective NHLBI CHAART-1 study. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 28, 9.
33.
go back to reference Lewis, W., Haase, C. P., Raidel, S. M., Russ, R. B., Sutliff, R. L., Hoit, B. D., et al. (2001). Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice. Laboratory Investigation, 81, 1527–1536.PubMed Lewis, W., Haase, C. P., Raidel, S. M., Russ, R. B., Sutliff, R. L., Hoit, B. D., et al. (2001). Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice. Laboratory Investigation, 81, 1527–1536.PubMed
34.
go back to reference Szabados, E., Fischerc, G. M., Toth, K., Csetev, B., Nemeti, B., Trombitas, K., et al. (1999). Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radical Biology and Medicine, 26, 309–317.CrossRefPubMed Szabados, E., Fischerc, G. M., Toth, K., Csetev, B., Nemeti, B., Trombitas, K., et al. (1999). Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radical Biology and Medicine, 26, 309–317.CrossRefPubMed
35.
go back to reference Lewis, W., Grupp, I., Grupp, G., Hoit, B., Morris, R., Samarel, A. M., et al. (2000). Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine. Laboratory Investigation, 80, 187–197.CrossRefPubMed Lewis, W., Grupp, I., Grupp, G., Hoit, B., Morris, R., Samarel, A. M., et al. (2000). Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine. Laboratory Investigation, 80, 187–197.CrossRefPubMed
36.
go back to reference Lewis, W., Haase, C. P., Miller, Y. K., Ferguson, B., Stuart, T., Ludaway, T., et al. (2005). Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS. Laboratory Investigation, 85, 972–981.CrossRefPubMed Lewis, W., Haase, C. P., Miller, Y. K., Ferguson, B., Stuart, T., Ludaway, T., et al. (2005). Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS. Laboratory Investigation, 85, 972–981.CrossRefPubMed
37.
go back to reference Gerschenson, M., Erhart, S. W., Paik, C. Y., St Claire, M. C., Nagashima, K., Skopets, B., et al. (2000). Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3′-azido-3′-deoxythymidine. AIDS Research and Human Retroviruses, 16, 635–644.CrossRefPubMed Gerschenson, M., Erhart, S. W., Paik, C. Y., St Claire, M. C., Nagashima, K., Skopets, B., et al. (2000). Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3′-azido-3′-deoxythymidine. AIDS Research and Human Retroviruses, 16, 635–644.CrossRefPubMed
38.
go back to reference Gerschenson, M., Nguyen, V., Ewings, E. L., Ceresa, A., Shaw, J. A., St Claire, M. C., et al. (2004). Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine. AIDS Research and Human Retroviruses, 20, 91–100.CrossRefPubMed Gerschenson, M., Nguyen, V., Ewings, E. L., Ceresa, A., Shaw, J. A., St Claire, M. C., et al. (2004). Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine. AIDS Research and Human Retroviruses, 20, 91–100.CrossRefPubMed
39.
go back to reference Divi, R. L., Leonard, S. L., Kuo, M. M., Walker, B. L., Orozco, C. C., St Claire, M. C., et al. (2005). Cardiac mitochondrial compromise in 1-yr-old Erythrocebus patas monkeys perinatally-exposed to nucleoside reverse transcriptase inhibitors. Cardiovascular Toxicology, 5, 333–346.CrossRefPubMed Divi, R. L., Leonard, S. L., Kuo, M. M., Walker, B. L., Orozco, C. C., St Claire, M. C., et al. (2005). Cardiac mitochondrial compromise in 1-yr-old Erythrocebus patas monkeys perinatally-exposed to nucleoside reverse transcriptase inhibitors. Cardiovascular Toxicology, 5, 333–346.CrossRefPubMed
40.
go back to reference Lebrecht, D., Geist, A., Ketelsen, U. P., Haberstroh, J., Setzer, B., & Walker, U. A. (2007). Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats. British Journal of Pharmacology, 51, 771–778.CrossRef Lebrecht, D., Geist, A., Ketelsen, U. P., Haberstroh, J., Setzer, B., & Walker, U. A. (2007). Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats. British Journal of Pharmacology, 51, 771–778.CrossRef
Metadata
Title
In Utero Exposure of Female CD-1 Mice to AZT and/or 3TC: I. Persistence of Microscopic Lesions in Cardiac Tissue
Authors
Salina M. Torres
Thomas H. March
Meghan M. Carter
Consuelo L. McCash
Steven K. Seilkop
Miriam C. Poirier
Dale M. Walker
Vernon E. Walker
Publication date
01-03-2010
Publisher
Humana Press Inc
Published in
Cardiovascular Toxicology / Issue 1/2010
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-010-9061-3

Other articles of this Issue 1/2010

Cardiovascular Toxicology 1/2010 Go to the issue